Which of the following drugs is contraindicated in a patient with porphyria?

Questions 144

ATI RN

ATI RN Test Bank

Pharmacology of CNS Drugs Questions

Question 1 of 5

Which of the following drugs is contraindicated in a patient with porphyria?

Correct Answer: D

Rationale: In this case, the correct answer is D) Phenobarbitone. Porphyria is a group of disorders characterized by an abnormal accumulation of porphyrins in the body, which can lead to symptoms like abdominal pain, neurological issues, and skin sensitivity to light. Phenobarbitone is contraindicated in patients with porphyria because it can trigger acute attacks due to its enzyme-inducing properties, leading to an exacerbation of symptoms. Now, let's discuss why the other options are incorrect: A) Zolpidem is a sedative-hypnotic primarily used for insomnia and is not known to exacerbate porphyria. B) Chloral hydrate is a sedative and hypnotic agent, but it is not typically associated with porphyria exacerbation. C) Buspirone is an anxiolytic medication that does not have known contraindications specifically related to porphyria. From an educational standpoint, understanding the contraindications of drugs in specific patient populations is crucial for safe prescribing practices. It highlights the importance of thorough patient assessments, including medical history, to avoid adverse drug reactions and complications. Students and healthcare professionals should be aware of such contraindications to provide optimal care and prevent harm to patients with specific conditions like porphyria.

Question 2 of 5

Which of the following statements about local anesthetic agents is correct?

Correct Answer: D

Rationale: The correct answer is D) Activity is enhanced by high extracellular K+ concentration. Local anesthetic agents work by blocking voltage-gated Na+ channels, preventing the influx of sodium ions and thus inhibiting the initiation and conduction of action potentials in neurons. High extracellular K+ concentration enhances the activity of local anesthetics by promoting a greater influx of the drug into the neuron through the concentration gradient. This phenomenon is known as the "ion trapping" effect, where the local anesthetic agent is more likely to exist in its lipid-soluble, active form in the presence of high extracellular K+. Option A is incorrect because local anesthetic agents primarily target Na+ channels rather than K+ channels. Option B is incorrect because local anesthetics actually prevent depolarization, not repolarization, by inhibiting the influx of sodium ions. Option C is incorrect because while vasodilators can improve the diffusion of local anesthetics in tissues, they do not directly prolong the local action of the anesthetic agent. Understanding the pharmacology of CNS drugs, including local anesthetics, is crucial for healthcare professionals such as nurses, pharmacists, and physicians. Knowing how these drugs work at the molecular level can help in their safe and effective administration, as well as in understanding potential drug interactions and side effects. This knowledge is essential for providing quality patient care and ensuring positive treatment outcomes.

Question 3 of 5

Commonalities of the sympathetic, parasympathetic, and somatic nervous systems involve which of the following neuroeffector transmitters?

Correct Answer: A

Rationale: The correct answer is A) Acetylcholine. Acetylcholine is the neurotransmitter common to the sympathetic, parasympathetic, and somatic nervous systems. This neurotransmitter is released at the neuroeffector junctions of the parasympathetic and sympathetic nervous systems as well as at the neuromuscular junction in the somatic nervous system. Dopamine (option B) is a neurotransmitter predominantly found in the central nervous system and is not a primary neuroeffector transmitter in the autonomic or somatic nervous systems. Epinephrine (option C) and norepinephrine (option D) are primarily neurotransmitters of the sympathetic nervous system, released by postganglionic neurons. While they play important roles in the sympathetic response, they are not shared across all three systems. Understanding the commonalities and differences in neuroeffector transmitters among the sympathetic, parasympathetic, and somatic nervous systems is crucial in pharmacology to target specific pathways for therapeutic interventions and minimize side effects. Acetylcholine's widespread role highlights its significance in mediating various physiological responses in the body.

Question 4 of 5

A medical student is performing a summer research project evaluating the pharmacologic effects of atropine at varying doses. Doses are extrapolated from normal human doses of this agent. Slow infusion of this agent to a steady state dose of 0.5 mg would be expected to produce which of the following effects?

Correct Answer: B

Rationale: In this scenario, the correct answer is B) Tachycardia. Atropine is a muscarinic antagonist that blocks the action of acetylcholine at muscarinic receptors. By inhibiting the parasympathetic nervous system, atropine causes an increase in heart rate (tachycardia). Bradykinesia (option A) refers to slowness of movement and is not a typical effect of atropine. Dilation of the pupils (option C) is a common effect of atropine due to its action on the iris sphincter muscle. Dry mouth (option D) is also a common side effect of atropine due to its anticholinergic properties. In an educational context, understanding the pharmacological effects of atropine is crucial for medical students as atropine is commonly used in clinical practice for various indications such as treating bradycardia, organophosphate poisoning, and intraocular procedures. Knowing the expected effects of atropine at different doses helps in clinical decision-making and patient management.

Question 5 of 5

A 37-year-old woman with hyperthyroidism and asthma has frequent asthma attacks, requiring inhalational albuterol and epinephrine. Her attacks are occurring several times per week. Her most recent blood tests reveal elevated \(T_3\) and \(T_4\) levels twice the normal values. These levels significantly increased from her last laboratory studies 6 months ago. What is the most likely explanation for these findings?

Correct Answer: B

Rationale: The correct answer is B) Supratherapeutic levels of exogenous thyroid hormone. In this case, the patient is experiencing hyperthyroidism, indicated by elevated \(T_3\) and \(T_4\) levels. Given that her levels are twice the normal values and increased significantly in just 6 months, it suggests an external source of thyroid hormone. Since her thyroid gland is not responsible for this excess production, the most likely explanation is the intake of exogenous thyroid hormone, possibly due to supratherapeutic dosing or inadvertent ingestion. Option A) Hypersensitivity vasculature response is incorrect because it does not explain the specific scenario of elevated thyroid hormone levels in a patient with hyperthyroidism and frequent asthma attacks. Option C) Neoplastic transformation is unlikely as there is no mention of any tumors or cancerous growth affecting the thyroid gland in the scenario. Option D) Thyroid gland infarct is also unlikely as it would lead to a decrease in thyroid hormone levels rather than the elevated levels observed in the patient. In an educational context, understanding the etiology of abnormal laboratory values is crucial in clinical practice. This scenario emphasizes the importance of considering exogenous sources of hormones and the implications of incorrect dosing or inadvertent ingestion in interpreting thyroid function tests. It also highlights the need for a comprehensive patient history and medication review to accurately diagnose and manage endocrine disorders.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions